Comparison of the outcomes of cytoreductive surgery versus surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: a propensity score matching analysis-Reference-Cited by-同舟云学术

Comparison of the outcomes of cytoreductive surgery versus surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: a propensity score matching analysis

Published:2020-07-06 Issue:6 Volume:35 Page:2789-2796
ISSN:0930-2794
Container-title:Surgical Endoscopy
language:en
Short-container-title:Surg Endosc

Author:

Li Zhou^ORCID,Redondo Ntutumu Juan de Dios,Huang Shengyi,Cai Zhai,Han Shuai,Balde A. I.,Luo Zeyu,Fang Suzhen

Funder

The Major Program of Science and Technology Planning Project of Guangzhou

Research Fund of Public Welfare in Health Industry, Health Ministry of China, and the Key Clinical Specialty Discipline Construction Program.

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00464-020-07712-3.pdf

Reference43 articles.

1. Glehen O et al (2003) Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:863–869

2. Sadeghi B et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358–363

3. de Cuba E, Kwakman R, Knol D, Bonjer H, Meijer G, Te Velde E (2013) Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev 39:321–327

4. Cao C, Yan T, Black D, Morris D (2009) A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 16:2152–2165

5. Franko J et al (2012) Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 30:263–267